Christophe Verny

3.1k total citations
58 papers, 1.8k citations indexed

About

Christophe Verny is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Christophe Verny has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 25 papers in Neurology and 18 papers in Molecular Biology. Recurrent topics in Christophe Verny's work include Genetic Neurodegenerative Diseases (40 papers), Neurological disorders and treatments (23 papers) and Mitochondrial Function and Pathology (14 papers). Christophe Verny is often cited by papers focused on Genetic Neurodegenerative Diseases (40 papers), Neurological disorders and treatments (23 papers) and Mitochondrial Function and Pathology (14 papers). Christophe Verny collaborates with scholars based in France, United States and United Kingdom. Christophe Verny's co-authors include Anne‐Catherine Bachoud‐Lévi, Dominique Bonneau, Véronique Gaura, Philippe Rémy, Pierre Krystkowiak, Philippe Allain, Pascal Reynier, Philippe Damier, Arnaud Chevrollier and Philippe Hantraye and has published in prestigious journals such as PLoS ONE, NeuroImage and Brain.

In The Last Decade

Christophe Verny

51 papers receiving 1.7k citations

Peers

Countries citing papers authored by Christophe Verny

Since Specialization

Citations

This map shows the geographic impact of Christophe Verny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Verny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Verny more than expected).

Fields of papers citing papers by Christophe Verny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Verny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Verny. The network helps show where Christophe Verny may publish in the future.

Co-authorship network of co-authors of Christophe Verny

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Verny. A scholar is included among the top collaborators of Christophe Verny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Verny. Christophe Verny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two Cases of ROSAH-Like Syndrome Restricted to the Ophthalmologic Presentation 2025 ·Ocular Immunology and Inflammation ·(unknown), (unknown), (unknown), Majida Charif, (unknown), (unknown), Patrizia Amati‐Bonneau, Agnès Guichet, Christian Lavigne, Christophe Verny, Philippe Gohier, Guy Lenaers	1
2	Camptocormia as a Phenotypic Variant of FSHD in the Elderly: Clinical, Genetic, and Imaging Features 2025 ·European Journal of Neurology ·(unknown), Patrick Vandeputte, (unknown), Christophe Gillet, Christophe Verny, Rafaëlle Bernard, Giorgio Tasca, Marco Spinazzi	0
3	Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD) 2025 ·Parkinsonism & Related Disorders ·Katia Youssov, Étienne Audureau, (unknown), Jean‐Philippe Azulay, Isabelle Bénatru, Alexandra Dürr, Pierre Krystkowiak, Cécilia Marelli, Christine Tranchant, C. Simonin, Christophe Verny, Anne‐Catherine Bachoud‐Lévi	0
4	Opa1 and MT-Nd6 mutations induce early mitochondrial changes in the retina and prelaminar optic nerve of hereditary optic neuropathy mouse models 2024 ·Brain Communications ·(unknown), Florence Manero, (unknown), (unknown), Christophe Verny, Arnaud Chevrollier, Guy Lenaers, Philippe Codron	0
5	The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs 2022 ·Parkinsonism & Related Disorders ·Katia Youssov, Étienne Audureau, (unknown), (unknown), Richard Layese, Cyril Goizet, Christophe Verny, (unknown), Anne‐Catherine Bachoud‐Lévi	8
6	Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes 2020 ·NeuroImage Clinical ·Jean‐François Mangin, Denis Rivière, Édouard Duchesnay, Yann Cointepas, Véronique Gaura, Christophe Verny, Philippe Damier, Pierre Krystkowiak, Anne‐Catherine Bachoud‐Lévi, Philippe Hantraye, Philippe Rémy, Gwenaëlle Douaud	19
7	Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's disease 2017 ·Neuropsychologia ·(unknown), Jérémy Besnard, Christophe Verny, Adriana Prundean, (unknown), Bénédicte Gohier, Dominique Bonneau, Nicole El Massioui, Philippe Allain	9
8	Guidelines for clinical pharmacological practices in Huntington's disease 2016 ·Revue Neurologique ·G. Désaméricq, Katia Youssov, Perrine Charles, (unknown), Audrey Olivier, (unknown), Christophe Verny, Anne‐Catherine Bachoud‐Lévi	5
9	How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease 2015 ·PLoS ONE ·Catherine Schramm, Sandrine Katsahian, Katia Youssov, Jean‐François Démonet, Pierre Krystkowiak, (unknown), Christophe Verny, Laurent Cléret de Langavant, Anne‐Catherine Bachoud‐Lévi	8
10	Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting 2015 ·PLoS ONE ·Laurent Cléret de Langavant, (unknown), Christophe Verny, Pierre Krystkowiak, C. Simonin, Philippe Damier, Jean‐François Démonet, (unknown), Amandine Rialland, David Schmitz, Patrick Maison, Katia Youssov, Anne‐Catherine Bachoud‐Lévi	8
11	Maculopathy and Spinocerebellar Ataxia Type 1 2013 ·Journal of Neuro-Ophthalmology ·Pierre Lebranchu, Guylène Le Meur, Armelle Magot, Albert David, Christophe Verny, (unknown), Dan Miléa	12
12	Les troubles visuels au cours de la maladie d’Alzheimer 2012 ·Journal Français d Ophtalmologie ·Stéphanie Leruez, (unknown), Frédérique Etcharry‐Bouyx, Christophe Verny, Olivier Beauchet, Dan Miléa	7
13	Validation of the first quality-of-life measurement for patients with Huntington’s disease 2012 ·International Clinical Psychopharmacology ·E. Clay, (unknown), J Dorey, Ferdinando Squitieri, Samuel Aballéa, Tiziana Martino, Joakim Tedroff, Daniel Zielonka, Pascal Auquier, Christophe Verny, Mondher Toumi	14
14	The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease 2011 ·Neuropsychologia ·Philippe Allain, Véronique Gaura, Luciano Fasotti, Valérie Chauviré, Adriana Prundean, (unknown), Dominique Bonneau, Anne‐Catherine Bachoud‐Lévi, Frédéric Dubas, Philippe Rémy, Didier Le Gall, Christophe Verny	10
15	High insulinlike growth factor I is associated with cognitive decline in Huntington disease 2010 ·Neurology ·(unknown), Stéphane Moutereau, Jean‐Philippe Azulay, Christophe Verny, C. Simonin, Christine Tranchant, (unknown), Anne‐Catherine Bachoud‐Lévi, Patrick Maison	41
16	In vivo evidence for the selective subcortical degeneration in Huntington's disease 2009 ·NeuroImage ·Gwenaëlle Douaud, Timothy E.J. Behrens, Cyril Poupon, Yann Cointepas, Saâd Jbabdi, Véronique Gaura, Narly Golestani, Pierre Krystkowiak, Christophe Verny, Philippe Damier, Anne‐Catherine Bachoud‐Lévi, Philippe Hantraye, Philippe Rémy	170
17	Hereditary optic neuropathies share a common mitochondrial coupling defect 2008 ·Annals of Neurology ·Arnaud Chevrollier, Virginie Guillet, Dominique Loiseau, Naïg Guéguen, Marie‐Anne Pou de Crescenzo, Christophe Verny, Marc Ferré, Hélène Dollfus, Sylvie Odent, Dan Miléa, Cyril Goizet, Patrizia Amati‐Bonneau, Vincent Procaccio, Dominique Bonneau, Pascal Reynier	94
18	Mitochondrial coupling defect in Charcot–Marie–Tooth type 2A disease 2007 ·Annals of Neurology ·Dominique Loiseau, Arnaud Chevrollier, Christophe Verny, Virginie Guillet, Naïg Guéguen, Marie‐Anne Pou de Crescenzo, Marc Ferré, Marie‐Claire Malinge, Agnès Guichet, Guillaume Nicolas, Patrizia Amati‐Bonneau, Yves Malthièry, Dominique Bonneau, Pascal Reynier	123
19	Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene 2007 ·European Journal of Neurology ·Christophe Verny, Philippe Allain, (unknown), Marie‐Claire Malinge, Bénédicte Gohier, (unknown), Dominique Bonneau, Frédéric Dubas, Didier Le Gall	51
20	Arithmetic word-problem-solving in Huntington’s disease 2004 ·Brain and Cognition ·Philippe Allain, Christophe Verny, Ghislaine Aubin, Karine Pinon, Dominique Bonneau, Frédéric Dubas, Didier Le Gall	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact